grzb Search Results


94
Elabscience Biotechnology mouse granzyme b elisa kit
Mouse Granzyme B Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/pm41861828-892-0-19?v=Elabscience+Biotechnology
Average 94 stars, based on 1 article reviews
mouse granzyme b elisa kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Addgene inc inert grabda sensor aav9 hsyn grab da mut
Inert Grabda Sensor Aav9 Hsyn Grab Da Mut, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/bio_rxiv__2025__05__23__655803-188-17-21?v=Addgene+inc
Average 93 stars, based on 1 article reviews
inert grabda sensor aav9 hsyn grab da mut - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

95
Addgene inc paav hsyn grab da2m
Paav Hsyn Grab Da2m, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/pmc11696184-465-8-14?v=Addgene+inc
Average 95 stars, based on 1 article reviews
paav hsyn grab da2m - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

93
Cusabio gzmb
ADSCs-Exos IFN−γ+TNF−α promoted immune escape of TNBC cells by transporting UCHL1. ADSCs were treated with 10 ng/mL IFN-γ and TNF-α, and transfected with si-NC or si-UCHL1. The exosomes were extracted from the supernatant. TNBC cells were treated with 10 μg/mL of the ADSCs-CM and different exosomes for 24 h, and then co-cultured with THP-1 cells for 48 h or with T cells for 16 h. A UCHL1 protein levels in TNBC cells in the indicated groups. B Viability of TNBC cells in the indicated groups. C Representative images showing Ki-67 expression in TNBC cells in the indicated groups. Scale bar = 100/25 μm. D Representative images showing migration of TNBC cells in the indicated groups. Scale bar = 100 μm. * P < 0.05 vs . MDA-MB-231 or MDA-MB-468. # P < 0.05 vs . Exos + MDA-MB-231 or Exos + MDA-MB-468. & P < 0.05 vs . Exos IFN−γ+TNF−α+con + MDA-MB-231 or Exos IFN−γ+TNF−α+con + MDA-MB-468. E The proportion of CD68 + CD206 + THP-1 cells in the indicated groups. F Arg-1, CD206, TNF-α, and iNOS expression in THP-1 cells. * P < 0.05 vs . THP-1. # P < 0.05 vs . MDA-MB-231 + THP-1 or MDA-MB-468 + THP-1. & P < 0.05 vs . Exos + THP-1. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + THP-1. G The proportion of CD3 + CD8 + T cells in the indicated groups. <t>H</t> <t>Perforin</t> and <t>GZMB</t> levels in T cells. * P < 0.05 vs . T cells. # P < 0.05 vs . MDA-MB-231 + T cells or MDA-MB-468 + T cells. & P < 0.05 vs . Exos + T cells. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + T cells
Gzmb, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/pmc11577656-175-11-13?v=Cusabio
Average 93 stars, based on 1 article reviews
gzmb - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Cusabio granzyme b
ADSCs-Exos IFN−γ+TNF−α promoted immune escape of TNBC cells by transporting UCHL1. ADSCs were treated with 10 ng/mL IFN-γ and TNF-α, and transfected with si-NC or si-UCHL1. The exosomes were extracted from the supernatant. TNBC cells were treated with 10 μg/mL of the ADSCs-CM and different exosomes for 24 h, and then co-cultured with THP-1 cells for 48 h or with T cells for 16 h. A UCHL1 protein levels in TNBC cells in the indicated groups. B Viability of TNBC cells in the indicated groups. C Representative images showing Ki-67 expression in TNBC cells in the indicated groups. Scale bar = 100/25 μm. D Representative images showing migration of TNBC cells in the indicated groups. Scale bar = 100 μm. * P < 0.05 vs . MDA-MB-231 or MDA-MB-468. # P < 0.05 vs . Exos + MDA-MB-231 or Exos + MDA-MB-468. & P < 0.05 vs . Exos IFN−γ+TNF−α+con + MDA-MB-231 or Exos IFN−γ+TNF−α+con + MDA-MB-468. E The proportion of CD68 + CD206 + THP-1 cells in the indicated groups. F Arg-1, CD206, TNF-α, and iNOS expression in THP-1 cells. * P < 0.05 vs . THP-1. # P < 0.05 vs . MDA-MB-231 + THP-1 or MDA-MB-468 + THP-1. & P < 0.05 vs . Exos + THP-1. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + THP-1. G The proportion of CD3 + CD8 + T cells in the indicated groups. <t>H</t> <t>Perforin</t> and <t>GZMB</t> levels in T cells. * P < 0.05 vs . T cells. # P < 0.05 vs . MDA-MB-231 + T cells or MDA-MB-468 + T cells. & P < 0.05 vs . Exos + T cells. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + T cells
Granzyme B, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/pmc11112810-160-33-36?v=Cusabio
Average 93 stars, based on 1 article reviews
granzyme b - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Addgene inc paav hsyn grab ne1m
ADSCs-Exos IFN−γ+TNF−α promoted immune escape of TNBC cells by transporting UCHL1. ADSCs were treated with 10 ng/mL IFN-γ and TNF-α, and transfected with si-NC or si-UCHL1. The exosomes were extracted from the supernatant. TNBC cells were treated with 10 μg/mL of the ADSCs-CM and different exosomes for 24 h, and then co-cultured with THP-1 cells for 48 h or with T cells for 16 h. A UCHL1 protein levels in TNBC cells in the indicated groups. B Viability of TNBC cells in the indicated groups. C Representative images showing Ki-67 expression in TNBC cells in the indicated groups. Scale bar = 100/25 μm. D Representative images showing migration of TNBC cells in the indicated groups. Scale bar = 100 μm. * P < 0.05 vs . MDA-MB-231 or MDA-MB-468. # P < 0.05 vs . Exos + MDA-MB-231 or Exos + MDA-MB-468. & P < 0.05 vs . Exos IFN−γ+TNF−α+con + MDA-MB-231 or Exos IFN−γ+TNF−α+con + MDA-MB-468. E The proportion of CD68 + CD206 + THP-1 cells in the indicated groups. F Arg-1, CD206, TNF-α, and iNOS expression in THP-1 cells. * P < 0.05 vs . THP-1. # P < 0.05 vs . MDA-MB-231 + THP-1 or MDA-MB-468 + THP-1. & P < 0.05 vs . Exos + THP-1. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + THP-1. G The proportion of CD3 + CD8 + T cells in the indicated groups. <t>H</t> <t>Perforin</t> and <t>GZMB</t> levels in T cells. * P < 0.05 vs . T cells. # P < 0.05 vs . MDA-MB-231 + T cells or MDA-MB-468 + T cells. & P < 0.05 vs . Exos + T cells. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + T cells
Paav Hsyn Grab Ne1m, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/bio_rxiv__2025__08__08__669345-136-21-24?v=Addgene+inc
Average 94 stars, based on 1 article reviews
paav hsyn grab ne1m - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
OriGene granzyme b
ADSCs-Exos IFN−γ+TNF−α promoted immune escape of TNBC cells by transporting UCHL1. ADSCs were treated with 10 ng/mL IFN-γ and TNF-α, and transfected with si-NC or si-UCHL1. The exosomes were extracted from the supernatant. TNBC cells were treated with 10 μg/mL of the ADSCs-CM and different exosomes for 24 h, and then co-cultured with THP-1 cells for 48 h or with T cells for 16 h. A UCHL1 protein levels in TNBC cells in the indicated groups. B Viability of TNBC cells in the indicated groups. C Representative images showing Ki-67 expression in TNBC cells in the indicated groups. Scale bar = 100/25 μm. D Representative images showing migration of TNBC cells in the indicated groups. Scale bar = 100 μm. * P < 0.05 vs . MDA-MB-231 or MDA-MB-468. # P < 0.05 vs . Exos + MDA-MB-231 or Exos + MDA-MB-468. & P < 0.05 vs . Exos IFN−γ+TNF−α+con + MDA-MB-231 or Exos IFN−γ+TNF−α+con + MDA-MB-468. E The proportion of CD68 + CD206 + THP-1 cells in the indicated groups. F Arg-1, CD206, TNF-α, and iNOS expression in THP-1 cells. * P < 0.05 vs . THP-1. # P < 0.05 vs . MDA-MB-231 + THP-1 or MDA-MB-468 + THP-1. & P < 0.05 vs . Exos + THP-1. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + THP-1. G The proportion of CD3 + CD8 + T cells in the indicated groups. <t>H</t> <t>Perforin</t> and <t>GZMB</t> levels in T cells. * P < 0.05 vs . T cells. # P < 0.05 vs . MDA-MB-231 + T cells or MDA-MB-468 + T cells. & P < 0.05 vs . Exos + T cells. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + T cells
Granzyme B, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/us12435361-324-39-42?v=OriGene
Average 93 stars, based on 1 article reviews
granzyme b - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

95
Proteintech granzyme b
ADSCs-Exos IFN−γ+TNF−α promoted immune escape of TNBC cells by transporting UCHL1. ADSCs were treated with 10 ng/mL IFN-γ and TNF-α, and transfected with si-NC or si-UCHL1. The exosomes were extracted from the supernatant. TNBC cells were treated with 10 μg/mL of the ADSCs-CM and different exosomes for 24 h, and then co-cultured with THP-1 cells for 48 h or with T cells for 16 h. A UCHL1 protein levels in TNBC cells in the indicated groups. B Viability of TNBC cells in the indicated groups. C Representative images showing Ki-67 expression in TNBC cells in the indicated groups. Scale bar = 100/25 μm. D Representative images showing migration of TNBC cells in the indicated groups. Scale bar = 100 μm. * P < 0.05 vs . MDA-MB-231 or MDA-MB-468. # P < 0.05 vs . Exos + MDA-MB-231 or Exos + MDA-MB-468. & P < 0.05 vs . Exos IFN−γ+TNF−α+con + MDA-MB-231 or Exos IFN−γ+TNF−α+con + MDA-MB-468. E The proportion of CD68 + CD206 + THP-1 cells in the indicated groups. F Arg-1, CD206, TNF-α, and iNOS expression in THP-1 cells. * P < 0.05 vs . THP-1. # P < 0.05 vs . MDA-MB-231 + THP-1 or MDA-MB-468 + THP-1. & P < 0.05 vs . Exos + THP-1. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + THP-1. G The proportion of CD3 + CD8 + T cells in the indicated groups. <t>H</t> <t>Perforin</t> and <t>GZMB</t> levels in T cells. * P < 0.05 vs . T cells. # P < 0.05 vs . MDA-MB-231 + T cells or MDA-MB-468 + T cells. & P < 0.05 vs . Exos + T cells. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + T cells
Granzyme B, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/pmc10991199-85-18-20?v=Proteintech
Average 95 stars, based on 1 article reviews
granzyme b - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

94
Elabscience Biotechnology human granzyme b elisa kit
Down-regulation of HMGB2 enhances the function of NK cells. (a) qRT-PCR analysis of HMGB2 mRNA levels in NK-92 cells transfected with siNC, siHMGB2 #1, siHMGB2 #2, and siHMGB2 #3. (b) Western blot analysis of HMGB2 protein levels in NK-92 cells transfected with siNC or siHMGB2. (c) The secretion levels of perforin-1 and granzyme B were measured by <t>ELISA</t> in NK-92 cells after HMGB2 knockdown. (d) Cytokine release (TNF-α and IFN-γ) from NK-92 cells with HMGB2 knock down were showed in histogram. (e) Cytotoxicity of NK-92 cells with HMGB2 knockdown against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) was assessed at 24h and 48h using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.
Human Granzyme B Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/pmc12634629-93-20-26?v=Elabscience+Biotechnology
Average 94 stars, based on 1 article reviews
human granzyme b elisa kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
OriGene anti granzyme b
Down-regulation of HMGB2 enhances the function of NK cells. (a) qRT-PCR analysis of HMGB2 mRNA levels in NK-92 cells transfected with siNC, siHMGB2 #1, siHMGB2 #2, and siHMGB2 #3. (b) Western blot analysis of HMGB2 protein levels in NK-92 cells transfected with siNC or siHMGB2. (c) The secretion levels of perforin-1 and granzyme B were measured by <t>ELISA</t> in NK-92 cells after HMGB2 knockdown. (d) Cytokine release (TNF-α and IFN-γ) from NK-92 cells with HMGB2 knock down were showed in histogram. (e) Cytotoxicity of NK-92 cells with HMGB2 knockdown against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) was assessed at 24h and 48h using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.
Anti Granzyme B, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/pm32782583-58-45-52?v=OriGene
Average 93 stars, based on 1 article reviews
anti granzyme b - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Addgene inc rgrab da1m
Down-regulation of HMGB2 enhances the function of NK cells. (a) qRT-PCR analysis of HMGB2 mRNA levels in NK-92 cells transfected with siNC, siHMGB2 #1, siHMGB2 #2, and siHMGB2 #3. (b) Western blot analysis of HMGB2 protein levels in NK-92 cells transfected with siNC or siHMGB2. (c) The secretion levels of perforin-1 and granzyme B were measured by <t>ELISA</t> in NK-92 cells after HMGB2 knockdown. (d) Cytokine release (TNF-α and IFN-γ) from NK-92 cells with HMGB2 knock down were showed in histogram. (e) Cytotoxicity of NK-92 cells with HMGB2 knockdown against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) was assessed at 24h and 48h using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.
Rgrab Da1m, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/pmc08647500-36-20-23?v=Addgene+inc
Average 93 stars, based on 1 article reviews
rgrab da1m - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
OriGene mouse monoclonal anti granzyme b
Down-regulation of HMGB2 enhances the function of NK cells. (a) qRT-PCR analysis of HMGB2 mRNA levels in NK-92 cells transfected with siNC, siHMGB2 #1, siHMGB2 #2, and siHMGB2 #3. (b) Western blot analysis of HMGB2 protein levels in NK-92 cells transfected with siNC or siHMGB2. (c) The secretion levels of perforin-1 and granzyme B were measured by <t>ELISA</t> in NK-92 cells after HMGB2 knockdown. (d) Cytokine release (TNF-α and IFN-γ) from NK-92 cells with HMGB2 knock down were showed in histogram. (e) Cytotoxicity of NK-92 cells with HMGB2 knockdown against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) was assessed at 24h and 48h using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.
Mouse Monoclonal Anti Granzyme B, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grzb/pmc07865330-70-40-44?v=OriGene
Average 90 stars, based on 1 article reviews
mouse monoclonal anti granzyme b - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


ADSCs-Exos IFN−γ+TNF−α promoted immune escape of TNBC cells by transporting UCHL1. ADSCs were treated with 10 ng/mL IFN-γ and TNF-α, and transfected with si-NC or si-UCHL1. The exosomes were extracted from the supernatant. TNBC cells were treated with 10 μg/mL of the ADSCs-CM and different exosomes for 24 h, and then co-cultured with THP-1 cells for 48 h or with T cells for 16 h. A UCHL1 protein levels in TNBC cells in the indicated groups. B Viability of TNBC cells in the indicated groups. C Representative images showing Ki-67 expression in TNBC cells in the indicated groups. Scale bar = 100/25 μm. D Representative images showing migration of TNBC cells in the indicated groups. Scale bar = 100 μm. * P < 0.05 vs . MDA-MB-231 or MDA-MB-468. # P < 0.05 vs . Exos + MDA-MB-231 or Exos + MDA-MB-468. & P < 0.05 vs . Exos IFN−γ+TNF−α+con + MDA-MB-231 or Exos IFN−γ+TNF−α+con + MDA-MB-468. E The proportion of CD68 + CD206 + THP-1 cells in the indicated groups. F Arg-1, CD206, TNF-α, and iNOS expression in THP-1 cells. * P < 0.05 vs . THP-1. # P < 0.05 vs . MDA-MB-231 + THP-1 or MDA-MB-468 + THP-1. & P < 0.05 vs . Exos + THP-1. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + THP-1. G The proportion of CD3 + CD8 + T cells in the indicated groups. H Perforin and GZMB levels in T cells. * P < 0.05 vs . T cells. # P < 0.05 vs . MDA-MB-231 + T cells or MDA-MB-468 + T cells. & P < 0.05 vs . Exos + T cells. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + T cells

Journal: Cancer Cell International

Article Title: Adipose stem cell exosomes, stimulated by pro-inflammatory factors, enhance immune evasion in triple-negative breast cancer by modulating the HDAC6/STAT3/PD-L1 pathway through the transporter UCHL1

doi: 10.1186/s12935-024-03557-1

Figure Lengend Snippet: ADSCs-Exos IFN−γ+TNF−α promoted immune escape of TNBC cells by transporting UCHL1. ADSCs were treated with 10 ng/mL IFN-γ and TNF-α, and transfected with si-NC or si-UCHL1. The exosomes were extracted from the supernatant. TNBC cells were treated with 10 μg/mL of the ADSCs-CM and different exosomes for 24 h, and then co-cultured with THP-1 cells for 48 h or with T cells for 16 h. A UCHL1 protein levels in TNBC cells in the indicated groups. B Viability of TNBC cells in the indicated groups. C Representative images showing Ki-67 expression in TNBC cells in the indicated groups. Scale bar = 100/25 μm. D Representative images showing migration of TNBC cells in the indicated groups. Scale bar = 100 μm. * P < 0.05 vs . MDA-MB-231 or MDA-MB-468. # P < 0.05 vs . Exos + MDA-MB-231 or Exos + MDA-MB-468. & P < 0.05 vs . Exos IFN−γ+TNF−α+con + MDA-MB-231 or Exos IFN−γ+TNF−α+con + MDA-MB-468. E The proportion of CD68 + CD206 + THP-1 cells in the indicated groups. F Arg-1, CD206, TNF-α, and iNOS expression in THP-1 cells. * P < 0.05 vs . THP-1. # P < 0.05 vs . MDA-MB-231 + THP-1 or MDA-MB-468 + THP-1. & P < 0.05 vs . Exos + THP-1. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + THP-1. G The proportion of CD3 + CD8 + T cells in the indicated groups. H Perforin and GZMB levels in T cells. * P < 0.05 vs . T cells. # P < 0.05 vs . MDA-MB-231 + T cells or MDA-MB-468 + T cells. & P < 0.05 vs . Exos + T cells. @ P < 0.05 vs . Exos IFN−γ+TNF−α+con + T cells

Article Snippet: Granular enzyme B (GZMB) and perforin levels were analyzed using specific GZMB (CSB-E08718h, CUSABIO, China) and perforin (CSB-E09313h, CUSABIO, China) ELISA kits according to the instructions.

Techniques: Transfection, Cell Culture, Expressing, Migration

ADSCs-Exos IFN−γ+TNF−α promoted tumor growth in vivo. BALB/c mice were subcutaneously injected with 4T1 cells (2 × 10 6 ) and treated with 100 μg of the different exosomes every 3 days. A Tumor weight and volume in the indicated groups. B In-situ expression of Ki-67 in the tumor tissues of indicated groups. Scale bar = 100/25 μm. C The F4/80 + /CD206 + cells in the tumor tissues of indicated groups. Scale bar = 25 μm. D The proportion of CD3 + CD8 + T cell in the tumor tissues of indicated groups. E Perforin and GZMB levels in the tumor tissues of indicated groups. F and G CD8 + /GZMB + cells and CD8 + /perforin + cells in the tumor tissues of indicated groups. (H) HDAC6, UCHL1, PD-L1, p-STAT3 and STAT3 levels in the tumors of indicated groups. * P < 0.05 vs . 4T1. # P < 0.05 vs . Exos + 4T1. & P < 0.05 vs . Exos IFN−γ+TNF−α+con + 4T1

Journal: Cancer Cell International

Article Title: Adipose stem cell exosomes, stimulated by pro-inflammatory factors, enhance immune evasion in triple-negative breast cancer by modulating the HDAC6/STAT3/PD-L1 pathway through the transporter UCHL1

doi: 10.1186/s12935-024-03557-1

Figure Lengend Snippet: ADSCs-Exos IFN−γ+TNF−α promoted tumor growth in vivo. BALB/c mice were subcutaneously injected with 4T1 cells (2 × 10 6 ) and treated with 100 μg of the different exosomes every 3 days. A Tumor weight and volume in the indicated groups. B In-situ expression of Ki-67 in the tumor tissues of indicated groups. Scale bar = 100/25 μm. C The F4/80 + /CD206 + cells in the tumor tissues of indicated groups. Scale bar = 25 μm. D The proportion of CD3 + CD8 + T cell in the tumor tissues of indicated groups. E Perforin and GZMB levels in the tumor tissues of indicated groups. F and G CD8 + /GZMB + cells and CD8 + /perforin + cells in the tumor tissues of indicated groups. (H) HDAC6, UCHL1, PD-L1, p-STAT3 and STAT3 levels in the tumors of indicated groups. * P < 0.05 vs . 4T1. # P < 0.05 vs . Exos + 4T1. & P < 0.05 vs . Exos IFN−γ+TNF−α+con + 4T1

Article Snippet: Granular enzyme B (GZMB) and perforin levels were analyzed using specific GZMB (CSB-E08718h, CUSABIO, China) and perforin (CSB-E09313h, CUSABIO, China) ELISA kits according to the instructions.

Techniques: In Vivo, Injection, In Situ, Expressing

Down-regulation of HMGB2 enhances the function of NK cells. (a) qRT-PCR analysis of HMGB2 mRNA levels in NK-92 cells transfected with siNC, siHMGB2 #1, siHMGB2 #2, and siHMGB2 #3. (b) Western blot analysis of HMGB2 protein levels in NK-92 cells transfected with siNC or siHMGB2. (c) The secretion levels of perforin-1 and granzyme B were measured by ELISA in NK-92 cells after HMGB2 knockdown. (d) Cytokine release (TNF-α and IFN-γ) from NK-92 cells with HMGB2 knock down were showed in histogram. (e) Cytotoxicity of NK-92 cells with HMGB2 knockdown against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) was assessed at 24h and 48h using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.

Journal: Frontiers in Immunology

Article Title: NK cell function down regulated by HMGB2 through ANGPT1/PI3K/AKT pathway and its effect on esophageal squamous carcinoma cells

doi: 10.3389/fimmu.2025.1666199

Figure Lengend Snippet: Down-regulation of HMGB2 enhances the function of NK cells. (a) qRT-PCR analysis of HMGB2 mRNA levels in NK-92 cells transfected with siNC, siHMGB2 #1, siHMGB2 #2, and siHMGB2 #3. (b) Western blot analysis of HMGB2 protein levels in NK-92 cells transfected with siNC or siHMGB2. (c) The secretion levels of perforin-1 and granzyme B were measured by ELISA in NK-92 cells after HMGB2 knockdown. (d) Cytokine release (TNF-α and IFN-γ) from NK-92 cells with HMGB2 knock down were showed in histogram. (e) Cytotoxicity of NK-92 cells with HMGB2 knockdown against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) was assessed at 24h and 48h using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.

Article Snippet: After centrifugation, the culture supernatant was collected, and the concentrations of granzyme B and perforin 1 were measured using the Human Granzyme B ELISA Kit (E-EL-H1617c, Elabscience, Beijing, China) and Human Perforin 1 ELISA Kit (E-EL-H1123c, Elabscience), respectively, according to the manufacturer’s instructions.

Techniques: Quantitative RT-PCR, Transfection, Western Blot, Enzyme-linked Immunosorbent Assay, Knockdown, Cytotoxicity Assay

Overexpression of HMGB2 inhibits the function of NK-92 cells. (a) qRT-PCR analysis of HMGB2 mRNA levels in NK-92 cells transfected with pcDNA3.1-Vector or pcDNA3.1-HMGB2. (b) Western blot analysis of HMGB2 protein expression in NK-92 cells transfected with pcDNA3.1-Vector or pcDNA3.1-HMGB2. (c) The secretion levels of perforin-1 and granzyme B were measured by ELISA in NK-92 cells after HMGB2 overexpression. (d) Cytokine release (TNF-α and IFN-γ) from NK-92 cells with HMGB2 overexpression was showed in histogram. (e) Cytotoxicity of NK-92 cells with HMGB2 overexpression against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) at 24h and 48h was assessed using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.

Journal: Frontiers in Immunology

Article Title: NK cell function down regulated by HMGB2 through ANGPT1/PI3K/AKT pathway and its effect on esophageal squamous carcinoma cells

doi: 10.3389/fimmu.2025.1666199

Figure Lengend Snippet: Overexpression of HMGB2 inhibits the function of NK-92 cells. (a) qRT-PCR analysis of HMGB2 mRNA levels in NK-92 cells transfected with pcDNA3.1-Vector or pcDNA3.1-HMGB2. (b) Western blot analysis of HMGB2 protein expression in NK-92 cells transfected with pcDNA3.1-Vector or pcDNA3.1-HMGB2. (c) The secretion levels of perforin-1 and granzyme B were measured by ELISA in NK-92 cells after HMGB2 overexpression. (d) Cytokine release (TNF-α and IFN-γ) from NK-92 cells with HMGB2 overexpression was showed in histogram. (e) Cytotoxicity of NK-92 cells with HMGB2 overexpression against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) at 24h and 48h was assessed using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.

Article Snippet: After centrifugation, the culture supernatant was collected, and the concentrations of granzyme B and perforin 1 were measured using the Human Granzyme B ELISA Kit (E-EL-H1617c, Elabscience, Beijing, China) and Human Perforin 1 ELISA Kit (E-EL-H1123c, Elabscience), respectively, according to the manufacturer’s instructions.

Techniques: Over Expression, Quantitative RT-PCR, Transfection, Plasmid Preparation, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay, Cytotoxicity Assay

Confirmation of HMGB2 knockout and functional assessment of KO-HMGB2 NK-92 cells. (a) Sanger sequencing chromatograms showing two distinct allelic edits in the KO-HMGB2 NK-92 cells. (b) Western blot analysis of HMGB2 protein levels in wild-type (WT) and KO-HMGB2 NK-92 cells. (c) ELISA analysis of perforin-1 and granzyme B secretion in supernatants collected from KO-HMGB2 and WT NK-92 cells co-cultured with KYSE450 cells for 12 hours. (d) qRT-PCR analysis of activating receptors (NKG2D, NKp44, NKp46, and CD107a) in KO-HMGB2 and WT NK-92 cells. (e) Cytotoxicity of NK-92 cells with HMGB2 knock out against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) at 24h and 48h was assessed using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.

Journal: Frontiers in Immunology

Article Title: NK cell function down regulated by HMGB2 through ANGPT1/PI3K/AKT pathway and its effect on esophageal squamous carcinoma cells

doi: 10.3389/fimmu.2025.1666199

Figure Lengend Snippet: Confirmation of HMGB2 knockout and functional assessment of KO-HMGB2 NK-92 cells. (a) Sanger sequencing chromatograms showing two distinct allelic edits in the KO-HMGB2 NK-92 cells. (b) Western blot analysis of HMGB2 protein levels in wild-type (WT) and KO-HMGB2 NK-92 cells. (c) ELISA analysis of perforin-1 and granzyme B secretion in supernatants collected from KO-HMGB2 and WT NK-92 cells co-cultured with KYSE450 cells for 12 hours. (d) qRT-PCR analysis of activating receptors (NKG2D, NKp44, NKp46, and CD107a) in KO-HMGB2 and WT NK-92 cells. (e) Cytotoxicity of NK-92 cells with HMGB2 knock out against various ESCC cell lines (EC109, KYSE70, KYSE150, KYSE450) at 24h and 48h was assessed using a cytotoxicity assay. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test for normally distributed data, or Kruskal–Wallis tests followed by Dunn’s post hoc tests for non-normally distributed data. * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the mean ± SD.

Article Snippet: After centrifugation, the culture supernatant was collected, and the concentrations of granzyme B and perforin 1 were measured using the Human Granzyme B ELISA Kit (E-EL-H1617c, Elabscience, Beijing, China) and Human Perforin 1 ELISA Kit (E-EL-H1123c, Elabscience), respectively, according to the manufacturer’s instructions.

Techniques: Knock-Out, Functional Assay, Sequencing, Western Blot, Enzyme-linked Immunosorbent Assay, Cell Culture, Quantitative RT-PCR, Cytotoxicity Assay